Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
[This corrects the article DOI: 10.1371/journal.pone.0281141.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624300 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0294194 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Acanthamoeba Keratitis Management and Prognostic Factors: A Systematic Review.
J Clin Med
April 2025
Department of Ophthalmology, Unidade Local de Saúde São João, 4200-319 Porto, Portugal.
: The aim of this study was to review the therapeutic and prognostic factors influencing Acanthamoeba Keratitis (AK) management. : A systematic search was performed across MEDLINE (via PubMed), Web of Science, and Scopus, following the PRISMA 2020 guidelines, and registered in PROSPERO (CRD420251010774). Studies reporting AK treatment regiments and prognostic factors were included.
View Article and Find Full Text PDFIntracameral voriconazole for severe fungal keratitis: a case series.
Arq Bras Oftalmol
January 2025
Department of Ophthalmology and Visual Sciences, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Purpose: This study aimed to report the use, efficacy, and safety of intracameral voriconazole as an adjuvant treatment for deep fungal keratitis.
Methods: This was a prospective case series of seven eyes with fungal keratitis with anterior chamber involvement or a corneal ulcer refractory to conventional topical treatment. In addition to topical treatment with 0.
In Vivo Confocal Microscopy Findings of a Rare Keratitis.
Ocul Immunol Inflamm
December 2024
Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Purpose: To report a rare case of fungal keratitis caused by , highlighting its unique morphological features using in vivo confocal microscopy (IVCM).
Methods: This was a retrospective case report. A 66-year-old man presented with foreign body sensation and blurred vision in his left eye for over 10 months.
Hydroxychloroquine and Chloroquine-Induced Cardiac Arrhythmias and Sudden Cardiac Death in Patients With Systemic Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis.
J Cardiovasc Pharmacol
August 2024
Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Hydroxychloroquine (HCQ) and chloroquine (CQ) are foundational treatments for several systemic autoimmune rheumatic diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Concerns regarding the risk of cardiac arrhythmia and death have been raised, yet the burden of HCQ and CQ-related cardiac toxicities remains unclear. A systematic literature search was conducted in the MEDLINE and Embase databases for articles published between the earliest date and April 2023 reporting cardiac conduction abnormalities in patients with systemic autoimmune rheumatic diseases taking HCQ or CQ.
View Article and Find Full Text PDFEvaluation of the Vitek 2 system for antifungal susceptibility testing of using a representative international panel of clinical isolates: overestimation of amphotericin B resistance and underestimation of fluconazole resistance.
J Clin Microbiol
April 2024
Clinical Microbiology Laboratory, "Attikon" University General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Article Synopsis
- * The Vitek 2 system showed poor agreement for certain antifungals like 5-flucytosine, fluconazole, and amphotericin B, but achieved moderate to high agreement for echinocandin drugs like micafungin and caspofungin.
- * Resistance was often misclassified, with the Vitek 2 underestimating fluconazole resistance and overestimating amphotericin B resistance, though using specific Vitek 2 values improved agreement rates